Insulin-like growth factor receptor I mediates resistance to anti-epidermal growth factor receptor therapy in primary human glioblastoma cells through continued activation of phosphoinositide 3-kinase signaling

Cancer Research

Volumn 62, Issue 1, 2002, Pages 200-207

  Chakravarti, Arnab ^a   Loeffler, Jay S ^a   Dyson, Nicholas J ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 (3 CHLOROANILINO) 6,7 DIMETHOXYQUINAZOLINE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN TYROSINE KINASE INHIBITOR; S6 KINASE; SOMATOMEDIN C RECEPTOR;

ANGIOGENESIS; APOPTOSIS; ARTICLE; CELL INVASION; CELL LINE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVATION; GLIOBLASTOMA; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

1-PHOSPHATIDYLINOSITOL 3-KINASE; APOPTOSIS; ARABIDOPSIS PROTEINS; ENZYME ACTIVATION; ENZYME INHIBITORS; GLIOBLASTOMA; HUMANS; NEOPLASM INVASIVENESS; PLANT PROTEINS; POTASSIUM CHANNELS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, IGF TYPE 1; RIBOSOMAL PROTEIN S6 KINASES; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED; TYRPHOSTINS;

EID: 0036141447     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Epidermal growth factor receptors: Critical mediators of multiple receptor pathways
2. Growth factor-specific signaling pathway stimulation and gene expression mediated by ErbB receptors
3. The epidermal growth factor receptor and its inhibition in cancer therapy
4. The EGF receptor as central transducer of heterologous signalling systems
5. Targeting signal transduction for disease therapy
6. Signal perception and transduction: The role of protein kinases
7. The akt/protein kinase B-dependent anti-apoptotic pathway and the mitogen-activated protein kinase cascade are alternatively activated in human glioblastoma multiforme
8. Epidermal growth factor-related peptides and their receptors in human malignancies
9. Akt, MAPK (Erk 1,2), and p38 act in concert to promote apoptosis in response to ErbB receptor family inhibition
10. Linking extracellular survival signals and the apoptotic machinery
11. Transformation and altered signal transduction by a naturally occurring mutant EGF receptor
12. Sustained mitogen-activated protein kinase activation is induced by transforming erbB receptor complexes
13. Inhibition of EGFR-mediated phosphoinositide-3-OH kinase (PI3-K) signaling and glioblastoma phenotype by signal regulatory proteins (SIRPs)
14. She regulates epidermal growth factor-induced activation of the JNK signaling pathway
15. p53-independent apoptosis: A mechanism of radiation-induced cell death of glioblastoma cells
16. The cell survival signal akt is differentially activated by PDGF-BB, EGF, and FGF-2 in osteoblastic cells
17. The relative role of ErbB1-4 receptor tyrosine kinases in radiation signal transduction responses of human carcinoma cells
18. The epidermal growth factor receptor as a target for therapy in breast carcinoma
19. Phase I studies of anti-epidermal growth factor receptor chimeric antibody C225 alone and in combination with cisplatin
20. Enhanced apoptosis with combination C225/radiation treatment serves as the impetus for clinical investigation in head and neck cancers
21. The effect of ionizing radiation on signal transduction: Antibodies to EGF receptor sensitize A431 cells to radiation
22. Antitumor activity of combined treatment of human cancer cells with ionizing radiation and anti-epidermal growth factor receptor monoclonal antibody C225 plus type I protein kinase A antisense oligonucleotide
23. Antitumor activity of sequential treatment with topotecan and anti-epidermal growth factor receptor monoclonal antibody C225
24. Radiation-induced release of transforming growth factor α activates the epidermal growth factor receptor and mitogen-activated protein kinase pathway in carcinoma cells, leading to increased proliferation and protection from radiation-induced cell death
25. Inhibition of epidermal growth factor receptor gene expression and function decreases proliferation of head and neck squamous cell carcinoma but not normal mucosal epithelial cells
26. The rapamycin-sensitive signal transduction pathway as a target for cancer therapy
27. Phase I and pharmacologic study of OSI-774, an epidermal growth factor receptor tyrosine kinase inhibitor, in patients with advanced solid malignancies
28. Modulation of radiation response after epidermal growth factor receptor blockade in squamous cell carcinomas: Inhibition of damage repair, cell cycle kinetics, and tumor angiogenesis
29. Epidermal growth factor receptor blockade with C225 modulates proliferation, apoptosis, and radiosensitivity in squamous cell carcinomas of the head and neck
30. In vivo enhancement of tumor radioresponse by C225 antiepidermal growth factor receptor antibody
31. Conversion of a radio-resistant phenotype to a more sensitive one by disabling ErbB receptor signaling in human cancer cells
32. Phase I study of anti-epidermal growth factor receptor antibody cetuximab in combination with radiation therapy in patients with advanced head and neck cancer
33. Prognostic and pathologic significance of quantitative protein expression profiling in human gliomas
34. Malignant glioma: Genetics and biology of a grave matter
35. Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas
36. Radiosensitization of malignant glioma cells through overexpression of dominant-negative epidermal growth factor receptor
37. Differential requirements of the MAP kinase and PI3 kinase signaling pathways in Src-versus insulin and IGF-I receptors-induced growth and transformation of rat intestinal epithelial cells
38. The IGF-I receptor in cell growth, transformation, and apoptosis
39. FAK is the upstream signal protein of the phosphatidylinositol 3-kinase-akt survival pathway in hydrogen peroxide-induced apoptosis of a human glioblastoma cell line
40. Akt activation protects hippocampal neurons from apoptosis by inhibiting transcriptional activity of p53
41. Regulation of neuronal survival by the serine-threonine protein kinase Akt
42. Transactivation-dependent and -independent control of neuronal survival by the PI3K-Akt signaling pathway
43. Scatter factor/hepatocyte growth factor protects against cytotoxic death in human glioblastoma via phosphatidylinositol 3-kinase- and akt-dependent pathways
44. Mechanisms and consequences of activation of protein kinase B/akt
45. Direct regulation of the Akt proto-oncogene product by phosphatidylinositol-3,4-biphosphonate
46. PI3-kinase inhibition: A target for drug development?
47. Anti-apoptotic signaling by hepatocyte growth factor/Met via the phosphatidylinositol 3-kinase/akt and mitogen-activated protein kinase pathways
48. Inhibition of the antiapoptotic pathway PI3K/akt/bad pathway by stress
49. p70S6 kinase signals cell survival as well as cell growth, inactivating the pro-apoptotic molecule BAD
50. The PI3-related kinases intercept conventional signaling pathways